Reveal molecular structural variation with Optical Genome Mapping

OGM is a novel genome mapping technology that offers unparalleled accuracy and resolution for a clear visualisation of the genome at the single-molecular level. This technology leverages advanced imaging techniques to detect structural variation across DNA, giving access to long-range genomic information associated with disease.

Source Genomics is dedicated to expanding its end-to-end genome mapping solutions through a broad portfolio of pan-omic research services. As OGM is more widely adopted across research, its innovative technology will open new avenues for understanding the genetic basis of disease, developing personalised therapies and unravelling the previously hidden complexities of genome structure.

Jay LeCoque, Executive Chairman and CEO, commented: “The Source Genomics business arm is vastly expanding its capabilities within the genomic space to support the biopharmaceutical and life science R&D industries in this new era of genomic discovery. We are particularly excited about the possibilities that Optical Genome Mapping brings to the field of genomics, where coupled with next-generation sequencing technologies, a comprehensive analysis of genomic constructs is possible.”